Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing.
Yang Y, Qiu JG, Li Y, Di JM, Zhang WJ, Jiang QW, Zheng DW, Chen Y, Wei MN, Huang JR, Wang K, Shi Z
Am J Transl Res. 2016 Sep 15;8(9):3986-3994. eCollection 2016.
(Link opens in a new window)
PubMed
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.